Publications by authors named "Jay A Lieberman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

644

Total Likes

34

Extended Reach

53,400

Social Features

23
A
Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis.
Marcus S Shaker, Dana V Wallace, David B K Golden, John Oppenheimer, Jonathan A Bernstein, Ronna L Campbell, Chitra Dinakar, Anne Ellis, Matthew Greenhawt, David A Khan

April 2020

Videos about Article: user user user 1

4 6 19 6 38

View All Article and Social Media Activity
A
Advances in the treatment of anaphylaxis: intranasal and sublingual versus intramuscular epinephrine.
Jay Adam Lieberman, Matthew Greenhawt

Curr Opin Allergy Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of the level of education on early peanut introduction and parental implementation.
Heema Shah, Margo Saharovici, Emily McCulley, Jason Yaun, Jay A Lieberman

Ann Allergy Asthma Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a validated, updated North American pediatric food allergy anaphylaxis management plan.
Aikaterini Anagnostou, Elissa M Abrams, William C Anderson, Melanie Carver, Sanaz Eftekhari, Jay A Lieberman

Ann Allergy Asthma Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapies relevant for the allergists are coming.
Jay A Lieberman

Ann Allergy Asthma Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in Food Anaphylaxis Management.
Jay A Lieberman, Elissa M Abrams, Priya Katari, Moshe Ben-Shoshan

J Allergy Clin Immunol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy.
Morna J Dorsey, Manish J Butte, Jay A Lieberman, Heather Lehman, Tracy Fausnight

J Clin Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94].
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, Timothy E Dribin, Elissa M Abrams

Ann Allergy Asthma Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of children with food allergies by allergists in the United States.
Aikaterini Anagnostou, Matthew Greenhawt, Jay A Lieberman, Christina E Ciaccio, Sayantani B Sindher

J Allergy Clin Immunol Glob· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and acceptability of a decision-aid for food allergy oral immunotherapy in children.
Aikaterini Anagnostou, Elissa M Abrams, Melanie Carver, Edmond S Chan, Sanaz Eftekhari, Jay A Lieberman

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting in Shape: Updates in Exercise Anaphylaxis.
Annette Carlisle, Jay Adam Lieberman

Curr Allergy Asthma Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Centered Practice Guidelines: GRADEing Evidence to Incorporate Certainty, Balance Between Benefits and Harms, Equity, Feasibility, and Cost-Effectiveness.
Ellen Stephen, Alexandra E Conway, Christopher D Codispoti, Elissa Abrams, Jay A Lieberman

J Allergy Clin Immunol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based use of epinephrine in anaphylaxis.
Catherine Hammond, Jay Adam Lieberman

Curr Opin Allergy Clin Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of novel therapies for urticaria and angioedema.
Jay A Lieberman

Ann Allergy Asthma Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, Timothy E Dribin, Elissa M Abrams

Ann Allergy Asthma Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update.
Julie Wang, Jay A Lieberman, Dana V Wallace, Susan Waserman, David B K Golden

J Allergy Clin Immunol Pract· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infant anaphylaxis and epinephrine use: Can we improve acute management?
Aikaterini Anagnostou, Matthew Greenhawt, S Shahzad Mustafa, Jay A Lieberman, Marcus Shaker

J Food Allergy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying thresholds of reaction for different foods.
Jay Adam Lieberman

J Food Allergy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient partnerships and minimally disruptive medicine.
S Shahzad Mustafa, Aikaterini Anagnostou, Matthew Greenhawt, Jay A Lieberman, Marcus Shaker

Ann Allergy Asthma Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled epinephrine for anaphylaxis: Time for another look?
Marcus S Shaker, David B K Golden, Jay A Lieberman, Matthew Greenhawt, Michael W Lee

Ann Allergy Asthma Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
For allergists, the solution is never violence!
Jonathan Spergel, Larry Borish, Mitchell H Grayson, Matthew J Greenhawt, Donald Y M Leung, Jay A Lieberman

Ann Allergy Asthma Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care provider.
Thomas B Casale, John Oppenheimer, Michael Kaliner, Jay A Lieberman, Richard Lowenthal

J Allergy Clin Immunol Pract· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring parental interest in a single, low-dose oral peanut challenge for their children with peanut allergy.
Lisa Biswas, Jay A Lieberman

Ann Allergy Asthma Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trials and tribulations of managing pediatric and adolescent asthma.
Jay A Lieberman

Ann Allergy Asthma Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eighty years from "non-reaginic" food allergy to now.
Jay A Lieberman

Ann Allergy Asthma Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answering the Call for Trustworthy Clinical Guidelines.
Marcus S Shaker, Jay A Lieberman, David M Lang

J Allergy Clin Immunol Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis